UniProt ID | CE290_HUMAN | |
---|---|---|
UniProt AC | O15078 | |
Protein Name | Centrosomal protein of 290 kDa | |
Gene Name | CEP290 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 2479 | |
Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite . Nucleus . Cell projection, cilium . Cytoplasm, cytoskeleton, cilium basal body . Cytoplasm, cyt | |
Protein Description | Involved in early and late steps in cilia formation. Its association with CCP110 is required for inhibition of primary cilia formation by CCP110. [PubMed: 18694559 May play a role in early ciliogenesis in the disappearance of centriolar satellites and in the transition of primary ciliar vesicles (PCVs) to capped ciliary vesicles (CCVs Required for the centrosomal recruitment of RAB8A and for the targeting of centriole satellite proteins to centrosomes such as of PCM1] | |
Protein Sequence | MPPNINWKEIMKVDPDDLPRQEELADNLLISLSKVEVNELKSEKQENVIHLFRITQSLMKMKAQEVELALEEVEKAGEEQAKFENQLKTKVMKLENELEMAQQSAGGRDTRFLRNEICQLEKQLEQKDRELEDMEKELEKEKKVNEQLALRNEEAENENSKLRRENKRLKKKNEQLCQDIIDYQKQIDSQKETLLSRRGEDSDYRSQLSKKNYELIQYLDEIQTLTEANEKIEVQNQEMRKNLEESVQEMEKMTDEYNRMKAIVHQTDNVIDQLKKENDHYQLQVQELTDLLKSKNEEDDPIMVAVNAKVEEWKLILSSKDDEIIEYQQMLHNLREKLKNAQLDADKSNVMALQQGIQERDSQIKMLTEQVEQYTKEMEKNTCIIEDLKNELQRNKGASTLSQQTHMKIQSTLDILKEKTKEAERTAELAEADAREKDKELVEALKRLKDYESGVYGLEDAVVEIKNCKNQIKIRDREIEILTKEINKLELKISDFLDENEALRERVGLEPKTMIDLTEFRNSKHLKQQQYRAENQILLKEIESLEEERLDLKKKIRQMAQERGKRSATSGLTTEDLNLTENISQGDRISERKLDLLSLKNMSEAQSKNEFLSRELIEKERDLERSRTVIAKFQNKLKELVEENKQLEEGMKEILQAIKEMQKDPDVKGGETSLIIPSLERLVNAIESKNAEGIFDASLHLKAQVDQLTGRNEELRQELRESRKEAINYSQQLAKANLKIDHLEKETSLLRQSEGSNVVFKGIDLPDGIAPSSASIINSQNEYLIHLLQELENKEKKLKNLEDSLEDYNRKFAVIRHQQSLLYKEYLSEKETWKTESKTIKEEKRKLEDQVQQDAIKVKEYNNLLNALQMDSDEMKKILAENSRKITVLQVNEKSLIRQYTTLVELERQLRKENEKQKNELLSMEAEVCEKIGCLQRFKEMAIFKIAALQKVVDNSVSLSELELANKQYNELTAKYRDILQKDNMLVQRTSNLEHLECENISLKEQVESINKELEITKEKLHTIEQAWEQETKLGNESSMDKAKKSITNSDIVSISKKITMLEMKELNERQRAEHCQKMYEHLRTSLKQMEERNFELETKFAELTKINLDAQKVEQMLRDELADSVSKAVSDADRQRILELEKNEMELKVEVSKLREISDIARRQVEILNAQQQSRDKEVESLRMQLLDYQAQSDEKSLIAKLHQHNVSLQLSEATALGKLESITSKLQKMEAYNLRLEQKLDEKEQALYYARLEGRNRAKHLRQTIQSLRRQFSGALPLAQQEKFSKTMIQLQNDKLKIMQEMKNSQQEHRNMENKTLEMELKLKGLEELISTLKDTKGAQKVINWHMKIEELRLQELKLNRELVKDKEEIKYLNNIISEYERTISSLEEEIVQQNKFHEERQMAWDQREVDLERQLDIFDRQQNEILNAAQKFEEATGSIPDPSLPLPNQLEIALRKIKENIRIILETRATCKSLEEKLKEKESALRLAEQNILSRDKVINELRLRLPATAEREKLIAELGRKEMEPKSHHTLKIAHQTIANMQARLNQKEEVLKKYQRLLEKAREEQREIVKKHEEDLHILHHRLELQADSSLNKFKQTAWDLMKQSPTPVPTNKHFIRLAEMEQTVAEQDDSLSSLLVKLKKVSQDLERQREITELKVKEFENIKLQLQENHEDEVKKVKAEVEDLKYLLDQSQKESQCLKSELQAQKEANSRAPTTTMRNLVERLKSQLALKEKQQKALSRALLELRAEMTAAAEERIISATSQKEAHLNVQQIVDRHTRELKTQVEDLNENLLKLKEALKTSKNRENSLTDNLNDLNNELQKKQKAYNKILREKEEIDQENDELKRQIKRLTSGLQGKPLTDNKQSLIEELQRKVKKLENQLEGKVEEVDLKPMKEKNAKEELIRWEEGKKWQAKIEGIRNKLKEKEGEVFTLTKQLNTLKDLFAKADKEKLTLQRKLKTTGMTVDQVLGIRALESEKELEELKKRNLDLENDILYMRAHQALPRDSVVEDLHLQNRYLQEKLHALEKQFSKDTYSKPSISGIESDDHCQREQELQKENLKLSSENIELKFQLEQANKDLPRLKNQVRDLKEMCEFLKKEKAEVQRKLGHVRGSGRSGKTIPELEKTIGLMKKVVEKVQRENEQLKKASGILTSEKMANIEQENEKLKAELEKLKAHLGHQLSMHYESKTKGTEKIIAENERLRKELKKETDAAEKLRIAKNNLEILNEKMTVQLEETGKRLQFAESRGPQLEGADSKSWKSIVVTRMYETKLKELETDIAKKNQSITDLKQLVKEATEREQKVNKYNEDLEQQIKILKHVPEGAETEQGLKRELQVLRLANHQLDKEKAELIHQIEANKDQSGAESTIPDADQLKEKIKDLETQLKMSDLEKQHLKEEIKKLKKELENFDPSFFEEIEDLKYNYKEEVKKNILLEEKVKKLSEQLGVELTSPVAASEEFEDEEESPVNFPIY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
31 | Phosphorylation | LADNLLISLSKVEVN HHHHHHHHHHHHCHH | 26.93 | 26074081 | |
78 (in isoform 2) | Ubiquitination | - | 52.36 | - | |
93 (in isoform 2) | Ubiquitination | - | 56.49 | 21890473 | |
102 (in isoform 2) | Ubiquitination | - | 36.13 | 21890473 | |
105 (in isoform 2) | Ubiquitination | - | 21.81 | 21890473 | |
140 | Acetylation | DMEKELEKEKKVNEQ HHHHHHHHHHHHHHH | 83.74 | 18528975 | |
185 | Ubiquitination | QDIIDYQKQIDSQKE HHHHHHHHHHHHHHH | 42.88 | - | |
191 | Ubiquitination | QKQIDSQKETLLSRR HHHHHHHHHHHHHHC | 57.53 | - | |
213 | Phosphorylation | SQLSKKNYELIQYLD HHHHHHHHHHHHHHH | 22.46 | - | |
348 | Phosphorylation | AQLDADKSNVMALQQ CCCCCHHHHHHHHHH | 34.89 | 20860994 | |
368 | Phosphorylation | DSQIKMLTEQVEQYT HHHHHHHHHHHHHHH | 22.37 | 29978859 | |
374 | Phosphorylation | LTEQVEQYTKEMEKN HHHHHHHHHHHHHHC | 13.28 | 23663014 | |
375 | Phosphorylation | TEQVEQYTKEMEKNT HHHHHHHHHHHHHCC | 21.88 | 23663014 | |
382 | Phosphorylation | TKEMEKNTCIIEDLK HHHHHHCCCCHHHHH | 19.02 | - | |
451 | Phosphorylation | ALKRLKDYESGVYGL HHHHHCHHHCCCCCH | 15.48 | 21712546 | |
456 | Phosphorylation | KDYESGVYGLEDAVV CHHHCCCCCHHHHEE | 21.37 | 21712546 | |
484 | Ubiquitination | REIEILTKEINKLEL HHHHHHHHHHHHHHC | 53.83 | - | |
512 | Ubiquitination | ERVGLEPKTMIDLTE HHHCCCCCCCEEHHH | 41.15 | - | |
527 | Ubiquitination | FRNSKHLKQQQYRAE HCCCHHHHHHHHHHH | 45.86 | - | |
567 | Phosphorylation | AQERGKRSATSGLTT HHHHCCCCCCCCCCH | 39.11 | 21406692 | |
569 | Phosphorylation | ERGKRSATSGLTTED HHCCCCCCCCCCHHH | 25.27 | 20068231 | |
570 | Phosphorylation | RGKRSATSGLTTEDL HCCCCCCCCCCHHHH | 31.36 | 21406692 | |
573 | Phosphorylation | RSATSGLTTEDLNLT CCCCCCCCHHHHCCC | 31.50 | 21406692 | |
574 | Phosphorylation | SATSGLTTEDLNLTE CCCCCCCHHHHCCCC | 32.32 | 21406692 | |
580 | Phosphorylation | TTEDLNLTENISQGD CHHHHCCCCCCCCCC | 26.39 | 20068231 | |
584 | Phosphorylation | LNLTENISQGDRISE HCCCCCCCCCCCCCH | 39.43 | 21406692 | |
593 | Ubiquitination | GDRISERKLDLLSLK CCCCCHHHHHHHHHC | 42.15 | - | |
598 | Phosphorylation | ERKLDLLSLKNMSEA HHHHHHHHHCCCCHH | 44.59 | 24719451 | |
600 | Ubiquitination | KLDLLSLKNMSEAQS HHHHHHHCCCCHHHH | 47.42 | - | |
608 | Ubiquitination | NMSEAQSKNEFLSRE CCCHHHHHHHHHCHH | 48.71 | - | |
672 | Phosphorylation | PDVKGGETSLIIPSL CCCCCCCCEEHHHCH | 31.91 | 27251275 | |
673 | Phosphorylation | DVKGGETSLIIPSLE CCCCCCCEEHHHCHH | 17.17 | 27251275 | |
688 | Phosphorylation | RLVNAIESKNAEGIF HHHHHHHCCCCCCCC | 25.70 | 24719451 | |
724 | Ubiquitination | QELRESRKEAINYSQ HHHHHHHHHHHHHHH | 61.86 | - | |
729 | Phosphorylation | SRKEAINYSQQLAKA HHHHHHHHHHHHHHC | 11.18 | 25003641 | |
730 | Phosphorylation | RKEAINYSQQLAKAN HHHHHHHHHHHHHCC | 13.63 | 25003641 | |
735 | Ubiquitination | NYSQQLAKANLKIDH HHHHHHHHCCCCCHH | 46.53 | 21890473 | |
737 (in isoform 1) | Ubiquitination | - | 40.95 | 21890473 | |
745 | Ubiquitination | LKIDHLEKETSLLRQ CCCHHHHHHHHHHHH | 73.06 | - | |
748 | Phosphorylation | DHLEKETSLLRQSEG HHHHHHHHHHHHCCC | 26.88 | 24719451 | |
820 | Phosphorylation | AVIRHQQSLLYKEYL HHHHHHHHHHHHHHH | 17.48 | 29083192 | |
823 | Phosphorylation | RHQQSLLYKEYLSEK HHHHHHHHHHHHCCC | 13.68 | 29083192 | |
826 | Phosphorylation | QSLLYKEYLSEKETW HHHHHHHHHCCCCCH | 16.04 | 29083192 | |
828 | Phosphorylation | LLYKEYLSEKETWKT HHHHHHHCCCCCHHC | 45.80 | 29083192 | |
830 | Ubiquitination | YKEYLSEKETWKTES HHHHHCCCCCHHCCC | 58.00 | 21890473 | |
832 | Phosphorylation | EYLSEKETWKTESKT HHHCCCCCHHCCCHH | 43.24 | - | |
832 (in isoform 1) | Ubiquitination | - | 43.24 | 21890473 | |
846 | Acetylation | TIKEEKRKLEDQVQQ HHHHHHHHHHHHHHH | 68.26 | 18584311 | |
859 | Acetylation | QQDAIKVKEYNNLLN HHHHHHHHHHHHHHH | 49.86 | 18584321 | |
883 | Phosphorylation | KKILAENSRKITVLQ HHHHHHCCCCEEEEE | 26.84 | - | |
895 | Phosphorylation | VLQVNEKSLIRQYTT EEEECHHHHHHHHHH | 23.89 | 19664995 | |
902 | Phosphorylation | SLIRQYTTLVELERQ HHHHHHHHHHHHHHH | 24.71 | - | |
951 | Ubiquitination | FKIAALQKVVDNSVS HHHHHHHHHHHCCCC | 45.11 | - | |
1002 | Phosphorylation | HLECENISLKEQVES HHHEECCCHHHHHHH | 44.99 | 24719451 | |
1017 | Phosphorylation | INKELEITKEKLHTI HHHHHHHHHHHHHHH | 24.63 | 24670416 | |
1023 | Phosphorylation | ITKEKLHTIEQAWEQ HHHHHHHHHHHHHHH | 36.32 | 29083192 | |
1032 | Phosphorylation | EQAWEQETKLGNESS HHHHHHHHHCCCCCH | 31.12 | 25599653 | |
1033 | Ubiquitination | QAWEQETKLGNESSM HHHHHHHHCCCCCHH | 54.36 | 21890473 | |
1035 (in isoform 1) | Ubiquitination | - | 37.10 | 21890473 | |
1042 | Ubiquitination | GNESSMDKAKKSITN CCCCHHHHHHHHCCH | 54.16 | 21890473 | |
1044 | Ubiquitination | ESSMDKAKKSITNSD CCHHHHHHHHCCHHH | 53.44 | - | |
1044 (in isoform 1) | Ubiquitination | - | 53.44 | 21890473 | |
1045 | Ubiquitination | SSMDKAKKSITNSDI CHHHHHHHHCCHHHH | 52.53 | 21890473 | |
1046 | Phosphorylation | SMDKAKKSITNSDIV HHHHHHHHCCHHHHH | 33.66 | 28555341 | |
1047 (in isoform 1) | Ubiquitination | - | 6.08 | 21890473 | |
1060 | Phosphorylation | VSISKKITMLEMKEL HHHHHHHHHHHHHHH | 25.28 | 20071362 | |
1125 | Phosphorylation | LRDELADSVSKAVSD HHHHHHHHHHHHCCH | 23.76 | 28060719 | |
1127 | Phosphorylation | DELADSVSKAVSDAD HHHHHHHHHHCCHHH | 20.89 | 28060719 | |
1131 | Phosphorylation | DSVSKAVSDADRQRI HHHHHHCCHHHHHHH | 31.76 | 28060719 | |
1159 | Phosphorylation | VSKLREISDIARRQV HHHHHHHHHHHHHHH | 20.43 | 21815630 | |
1178 | Ubiquitination | AQQQSRDKEVESLRM HHHHHCHHHHHHHHH | 63.65 | - | |
1209 | Phosphorylation | KLHQHNVSLQLSEAT HHHHCCCEEEEHHHH | 18.73 | 18187866 | |
1251 | Phosphorylation | EKEQALYYARLEGRN HHHHHHHHHHHHCCH | 6.01 | 18083107 | |
1287 | Phosphorylation | LAQQEKFSKTMIQLQ HHHHHHHHHHHHHHH | 37.98 | 27174698 | |
1289 | Phosphorylation | QQEKFSKTMIQLQND HHHHHHHHHHHHHHH | 20.50 | 27174698 | |
1336 | Ubiquitination | EELISTLKDTKGAQK HHHHHHHHCCCCHHH | 64.54 | - | |
1360 | Ubiquitination | ELRLQELKLNRELVK HHHHHHHCCCHHHHC | 42.85 | - | |
1382 (in isoform 2) | Ubiquitination | - | 12.15 | 21890473 | |
1385 | Phosphorylation | IISEYERTISSLEEE HHHHHHHHHHHHHHH | 17.17 | 27050516 | |
1517 | Ubiquitination | PATAEREKLIAELGR CCHHHHHHHHHHHCC | 51.95 | - | |
1552 | Ubiquitination | MQARLNQKEEVLKKY HHHHHHHHHHHHHHH | 55.56 | - | |
1594 | Phosphorylation | RLELQADSSLNKFKQ HHHHHCCCCHHHHHH | 39.48 | 20873877 | |
1595 | Phosphorylation | LELQADSSLNKFKQT HHHHCCCCHHHHHHH | 36.19 | 20873877 | |
1598 | Ubiquitination | QADSSLNKFKQTAWD HCCCCHHHHHHHHHH | 60.27 | - | |
1600 | Ubiquitination | DSSLNKFKQTAWDLM CCCHHHHHHHHHHHH | 48.63 | - | |
1608 | Ubiquitination | QTAWDLMKQSPTPVP HHHHHHHHCCCCCCC | 55.72 | - | |
1610 | Phosphorylation | AWDLMKQSPTPVPTN HHHHHHCCCCCCCCC | 25.81 | 28985074 | |
1618 | Ubiquitination | PTPVPTNKHFIRLAE CCCCCCCHHHHHHHH | 42.23 | - | |
1636 | Phosphorylation | TVAEQDDSLSSLLVK HHHHCCCCHHHHHHH | 38.14 | 22210691 | |
1638 | Phosphorylation | AEQDDSLSSLLVKLK HHCCCCHHHHHHHHH | 23.92 | 22210691 | |
1639 | Phosphorylation | EQDDSLSSLLVKLKK HCCCCHHHHHHHHHH | 30.89 | 22210691 | |
1658 | Phosphorylation | LERQREITELKVKEF HHHHHHHHHHHHHHH | 30.43 | 23403867 | |
1684 | Acetylation | EDEVKKVKAEVEDLK HHHHHHHHHHHHHHH | 47.94 | 7677519 | |
1691 | Acetylation | KAEVEDLKYLLDQSQ HHHHHHHHHHHHHHH | 46.29 | 7677529 | |
1692 | Phosphorylation | AEVEDLKYLLDQSQK HHHHHHHHHHHHHHH | 21.57 | 28122231 | |
1697 | Phosphorylation | LKYLLDQSQKESQCL HHHHHHHHHHHHHHH | 42.77 | 25599653 | |
1731 | Acetylation | RNLVERLKSQLALKE HHHHHHHHHHHHHHH | 42.23 | 12655493 | |
1737 | Acetylation | LKSQLALKEKQQKAL HHHHHHHHHHHHHHH | 58.20 | 12655503 | |
1788 | Ubiquitination | DRHTRELKTQVEDLN HHHHHHHHHHHHHHH | 31.96 | - | |
1814 | Phosphorylation | TSKNRENSLTDNLND HCCCHHHHHHHCHHH | 28.08 | 25072903 | |
1816 | Phosphorylation | KNRENSLTDNLNDLN CCHHHHHHHCHHHHH | 23.74 | 25072903 | |
1828 | Acetylation | DLNNELQKKQKAYNK HHHHHHHHHHHHHHH | 70.56 | 20167786 | |
1833 | Phosphorylation | LQKKQKAYNKILREK HHHHHHHHHHHHHHH | 24.83 | 29457462 | |
1840 | Acetylation | YNKILREKEEIDQEN HHHHHHHHHHHHHHC | 54.97 | 20167786 | |
1864 | Ubiquitination | LTSGLQGKPLTDNKQ HHHCCCCCCCCCCHH | 24.72 | - | |
1906 | Ubiquitination | PMKEKNAKEELIRWE HCCCCCHHHHHHHHH | 62.20 | - | |
1916 | Methylation | LIRWEEGKKWQAKIE HHHHHHHHHHHHHHH | 54.86 | 23644510 | |
1921 | Methylation | EGKKWQAKIEGIRNK HHHHHHHHHHHHHHH | 26.62 | 23644510 | |
1959 | Phosphorylation | KADKEKLTLQRKLKT HHCHHHCHHHHHHHH | 31.73 | - | |
1966 | Phosphorylation | TLQRKLKTTGMTVDQ HHHHHHHHCCCCHHH | 38.73 | - | |
1982 | Phosphorylation | LGIRALESEKELEEL HHHHHHHCHHHHHHH | 55.61 | 26471730 | |
2002 | Phosphorylation | DLENDILYMRAHQAL CCHHCHHHHHHHHCC | 5.72 | - | |
2013 | Phosphorylation | HQALPRDSVVEDLHL HHCCCCCCHHHHHHH | 29.37 | 28348404 | |
2034 | Ubiquitination | EKLHALEKQFSKDTY HHHHHHHHHHCCCCC | 58.45 | - | |
2043 | Ubiquitination | FSKDTYSKPSISGIE HCCCCCCCCCCCCCC | 32.16 | - | |
2045 | Phosphorylation | KDTYSKPSISGIESD CCCCCCCCCCCCCCC | 32.87 | 27251275 | |
2069 | Phosphorylation | QKENLKLSSENIELK HHHHHCCCHHHHHHH | 33.74 | 20068231 | |
2070 | Phosphorylation | KENLKLSSENIELKF HHHHCCCHHHHHHHH | 45.13 | 20068231 | |
2126 | Phosphorylation | GSGRSGKTIPELEKT CCCCCCCCHHHHHHH | 45.34 | - | |
2133 | Phosphorylation | TIPELEKTIGLMKKV CHHHHHHHHHHHHHH | 15.76 | 27155012 | |
2155 | Phosphorylation | NEQLKKASGILTSEK HHHHHHHHCCCCHHH | 34.93 | 20860994 | |
2172 | Ubiquitination | NIEQENEKLKAELEK CHHHHHHHHHHHHHH | 67.86 | - | |
2189 | Phosphorylation | AHLGHQLSMHYESKT HHHHHHHHHHHHCCC | 9.28 | 27251275 | |
2238 | Phosphorylation | EILNEKMTVQLEETG HHHCHHCEEEHHHHH | 19.03 | 27174698 | |
2244 | Phosphorylation | MTVQLEETGKRLQFA CEEEHHHHHCCHHHH | 38.33 | 27174698 | |
2284 | Phosphorylation | TKLKELETDIAKKNQ HHHHHHHHHHHHHCC | 45.38 | - | |
2292 | Phosphorylation | DIAKKNQSITDLKQL HHHHHCCCHHHHHHH | 36.53 | 26471730 | |
2294 | Phosphorylation | AKKNQSITDLKQLVK HHHCCCHHHHHHHHH | 40.29 | 26471730 | |
2304 | Phosphorylation | KQLVKEATEREQKVN HHHHHHHHHHHHHHH | 36.35 | 16674116 | |
2322 | Ubiquitination | EDLEQQIKILKHVPE HHHHHHHHHHHCCCC | 37.33 | 21890473 | |
2324 (in isoform 1) | Ubiquitination | - | 2.39 | 21890473 | |
2338 | Ubiquitination | AETEQGLKRELQVLR CCCHHHHHHHHHHHH | 51.13 | - | |
2369 | Phosphorylation | IEANKDQSGAESTIP HHHCCCCCCCCCCCC | 50.53 | 26471730 | |
2373 | Phosphorylation | KDQSGAESTIPDADQ CCCCCCCCCCCCHHH | 30.97 | 29083192 | |
2374 | Phosphorylation | DQSGAESTIPDADQL CCCCCCCCCCCHHHH | 28.21 | 28985074 | |
2395 | Phosphorylation | LETQLKMSDLEKQHL HHHHHHHHHHHHHHH | 37.14 | 19413330 | |
2437 | Acetylation | NYKEEVKKNILLEEK CCHHHHHHHHHHHHH | 55.16 | 20167786 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CE290_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CE290_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
610188 | Joubert syndrome 5 (JBTS5) | |||||
610189 | Senior-Loken syndrome 6 (SLSN6) | |||||
611755 | Leber congenital amaurosis 10 (LCA10) | |||||
611134 | Meckel syndrome 4 (MKS4) | |||||
0000269|PubMed | Note=Antibodies against CEP290 are present in sera from patients with cutaneous T-cell lymphomas, but not in the healthy control population. {ECO | |||||
615991 | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2395, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1209, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1697, AND MASSSPECTROMETRY. |